Compare Newmont Corporation (NEM) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Newmont Corporation vs Novavax Inc — how do they compare? Newmont Corporation trades at $92.41 (market cap $95.23B), while Novavax Inc trades at $8.08 (market cap $1.30B). The key difference: Newmont Corporation is far larger — about 73.3× Novavax Inc's market cap, and Newmont Corporation pays a 1.17% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NEM | NVAX | |
|---|---|---|
Market Cap | $95.23B | $1.30B |
Sector | Basic Materials | Health |
52-Week High | $131.95 | $11.19 |
52-Week Low | $59.86 | $6.22 |
Enterprise Value | $91.98B | $800.50M |
Dividend Yield | 1.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Newmont Corporation
Newmont Corp is primarily a gold producer with operations and/or assets in the United States, Canada, Mexico, Dominican Republic, Peru, Suriname, Argentina, Chile, Australia, and Ghana. It is also engaged in the production of copper, silver, lead and zinc. The company's operations are organized in five geographic regions: North America, South America, Australia, Africa and Nevada.
Read more on NEM →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
